Cargando…

A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film

BACKGROUND: Intensity modulated radiation therapy (IMRT) is an advanced method for delivery of three dimensional therapies, which provides optimal dose distribution with giving multiple nonuniform fluency to the patient. The complex dose distribution of IMRT should be checked to ensure that the accu...

Descripción completa

Detalles Bibliográficos
Autores principales: Falahati, F., Nickfarjam, A., Shabani, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Biomedical Physics and Engineering 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280119/
https://www.ncbi.nlm.nih.gov/pubmed/30568924
_version_ 1783378605844201472
author Falahati, F.
Nickfarjam, A.
Shabani, M.
author_facet Falahati, F.
Nickfarjam, A.
Shabani, M.
author_sort Falahati, F.
collection PubMed
description BACKGROUND: Intensity modulated radiation therapy (IMRT) is an advanced method for delivery of three dimensional therapies, which provides optimal dose distribution with giving multiple nonuniform fluency to the patient. The complex dose distribution of IMRT should be checked to ensure that the accurate dose is delivered. Today, film dosimetry is a powerful tool for radiotherapy treatment Quality Assurance (QA) and a good method to verify dose distribution in phantoms. OBJECTIVE: This study aimed to evaluate the accuracy of IMRT treatment planning system, Prowess Panther(®) software, with Gafchromic EBT3 films in a inhomogeneity phantom. MATERIAL AND METHODS: The IMRT plan was generated by Prowess Panther(®) treatment planning system (TPS) version 5.2 on a inhomogeneity phantom, then it was irradiated by ONCOR linear accelerator (Linac) with 6 (MV) photon beam energy. The Gafchromic EBT3 film located between the phantom has measured the dose distribution. To compare between TPS calculated doses and film measured doses, Gamma criteria 3%/3 mm, 4%/4 mm, 5%/5 mm, 6%/6 mm and 7%/7 mm Dose Difference (DD) and Distance to Agreement (DTA), respectively were used. RESULTS: Gammas passing rates for PTV are obtained 67.5% for 3%/3mm, 78.8% for 4%/4mm, 86.3% for 5%/5mm, 91.2% for 6%/6mm and 94.3% for 7%/7mm and for organs at risk is 72.4% for 3%/3mm, 82.8% for 4%/4mm, 89.8% for 5%/5mm, 93.3% for 6%/6mm and 95.4% for 7%/7mm (respectively DD/DTA). By increasing the range of criteria the capability increased. CONCLUSION: The results show that the use of EBT3 film in a inhomogeneity phantoms allows us to evaluate the dose differences between the EBT3 measured dose distribution and TPS calculated dose distribution .Hence, a result Prowess Panther(®) TPS can be used for IMRT technique treatment.
format Online
Article
Text
id pubmed-6280119
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Journal of Biomedical Physics and Engineering
record_format MEDLINE/PubMed
spelling pubmed-62801192018-12-19 A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film Falahati, F. Nickfarjam, A. Shabani, M. J Biomed Phys Eng Original Article BACKGROUND: Intensity modulated radiation therapy (IMRT) is an advanced method for delivery of three dimensional therapies, which provides optimal dose distribution with giving multiple nonuniform fluency to the patient. The complex dose distribution of IMRT should be checked to ensure that the accurate dose is delivered. Today, film dosimetry is a powerful tool for radiotherapy treatment Quality Assurance (QA) and a good method to verify dose distribution in phantoms. OBJECTIVE: This study aimed to evaluate the accuracy of IMRT treatment planning system, Prowess Panther(®) software, with Gafchromic EBT3 films in a inhomogeneity phantom. MATERIAL AND METHODS: The IMRT plan was generated by Prowess Panther(®) treatment planning system (TPS) version 5.2 on a inhomogeneity phantom, then it was irradiated by ONCOR linear accelerator (Linac) with 6 (MV) photon beam energy. The Gafchromic EBT3 film located between the phantom has measured the dose distribution. To compare between TPS calculated doses and film measured doses, Gamma criteria 3%/3 mm, 4%/4 mm, 5%/5 mm, 6%/6 mm and 7%/7 mm Dose Difference (DD) and Distance to Agreement (DTA), respectively were used. RESULTS: Gammas passing rates for PTV are obtained 67.5% for 3%/3mm, 78.8% for 4%/4mm, 86.3% for 5%/5mm, 91.2% for 6%/6mm and 94.3% for 7%/7mm and for organs at risk is 72.4% for 3%/3mm, 82.8% for 4%/4mm, 89.8% for 5%/5mm, 93.3% for 6%/6mm and 95.4% for 7%/7mm (respectively DD/DTA). By increasing the range of criteria the capability increased. CONCLUSION: The results show that the use of EBT3 film in a inhomogeneity phantoms allows us to evaluate the dose differences between the EBT3 measured dose distribution and TPS calculated dose distribution .Hence, a result Prowess Panther(®) TPS can be used for IMRT technique treatment. Journal of Biomedical Physics and Engineering 2018-12-01 /pmc/articles/PMC6280119/ /pubmed/30568924 Text en Copyright: © Journal of Biomedical Physics and Engineering http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Falahati, F.
Nickfarjam, A.
Shabani, M.
A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
title A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
title_full A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
title_fullStr A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
title_full_unstemmed A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
title_short A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
title_sort feasibility study of imrt of lung cancer using gafchromic ebt3 film
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280119/
https://www.ncbi.nlm.nih.gov/pubmed/30568924
work_keys_str_mv AT falahatif afeasibilitystudyofimrtoflungcancerusinggafchromicebt3film
AT nickfarjama afeasibilitystudyofimrtoflungcancerusinggafchromicebt3film
AT shabanim afeasibilitystudyofimrtoflungcancerusinggafchromicebt3film
AT falahatif feasibilitystudyofimrtoflungcancerusinggafchromicebt3film
AT nickfarjama feasibilitystudyofimrtoflungcancerusinggafchromicebt3film
AT shabanim feasibilitystudyofimrtoflungcancerusinggafchromicebt3film